Cisplatin, Dacarbazine, and Fotemustine plus Interferon a in Patients with Advanced Malignant Melanoma A Multicenter Phase II Study of the Southern Italy Cooperative Oncology Group

Authors :: Daponte A
Ascierto PA
Gravina A
Melucci MT
Palmieri G
Comella P
Cellerino R
De Lena M
Marini G
Comella G.
Source :: Cancer, 89 (2000): 2630–2636., info:cnr-pdr/source/autori:Daponte A, Ascierto PA, Gravina A, Melucci MT, Palmieri G, Comella P, Cellerino R, De Lena M, Marini G, Comella G./titolo:Cisplatin, Dacarbazine, and Fotemustine plus Interferon a in Patients with Advanced Malignant Melanoma A Multicenter Phase II Study of the Southern Italy Cooperative Oncology Group/doi:/rivista:Cancer (Print)/anno:2000/pagina_da:2630/pagina_a:2636/intervallo_pagine:2630–2636/volume:89
Publication Year :: 2000
Publisher :: Published for the American Cancer Society by Wiley Subscription Services, Inc., Hoboken, N.J., Stati Uniti d'America, 2000.

Language :: English
Database :: OpenAIRE
Journal :: Cancer, 89 (2000): 2630–2636., info:cnr-pdr/source/autori:Daponte A, Ascierto PA, Gravina A, Melucci MT, Palmieri G, Comella P, Cellerino R, De Lena M, Marini G, Comella G./titolo:Cisplatin, Dacarbazine, and Fotemustine plus Interferon a in Patients with Advanced Malignant Melanoma A Multicenter Phase II Study of the Southern Italy Cooperative Oncology Group/doi:/rivista:Cancer (Print)/anno:2000/pagina_da:2630/pagina_a:2636/intervallo_pagine:2630–2636/volume:89
Accession number :: edsair.cnr...........da3ac63570017aa7c9d2c9fdbef912eb

Tools